Comments
Loading...
Viking Therapeutics (VKTX) Forecast
NewsEarningsViking Therapeutics (VKTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestViking Therapeutics (NASDAQ:VKTX) Stock Quotes, Forecast and News Summary
Viking Therapeutics Stock (NASDAQ: VKTX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Viking Therapeutics (VKTX) stock?
You can purchase shares of Viking Therapeutics (NASDAQ:VKTX) through any online brokerage.
Who are Viking Therapeutics (VKTX) competitors?
Other companies in Viking Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE) and Exact Sciences (NASDAQ:EXAS).
What is the forecast, or price target, for Viking Therapeutics (VKTX) stock?
Viking Therapeutics has a consensus price target of $80.67.
What is the current price for Viking Therapeutics (VKTX)?
The stock price for Viking Therapeutics (NASDAQ: VKTX) is $48.72 last updated November 18, 2024 at 3:10 PM EST.
Does Viking Therapeutics (VKTX) pay a dividend?
There are no upcoming dividends for Viking Therapeutics.
When is Viking Therapeutics (NASDAQ:VKTX) reporting earnings?
Viking Therapeutics’s Q4 earnings are confirmed for Wednesday, February 5, 2025.
Is Viking Therapeutics (VKTX) going to split?
There is no upcoming split for Viking Therapeutics.
What sector and industry does Viking Therapeutics (VKTX) operate in?
Viking Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.